VXRT

Vaxart Stock Price

6.39
-0.99 (-13.41%)
Upgrade to Real-Time
Regular Market
6.39

Low
2.10

52 Week Range

High
24.90

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Vaxart Inc VXRT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.99 -13.41% 6.39 11:07:16
Open Price Low Price High Price Close Price Prev Close
6.80 6.33 6.80 7.38
Bid Price Ask Price Spread News
6.39 6.40 0.01 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
38,009 11,018,518 $ 6.53 $ 71,961,463 26,752,211 2.10 - 24.90
Last Trade Time Type Quantity Stock Price Currency
11:07:21 400 $ 6.39 USD

Vaxart Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 752.35M 117.77M 91.83M $ 4.05M $ - -0.35 -30.80
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% -150.00k 2.30%

more financials information »

Vaxart News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical VXRT Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week9.6911.1086.339.1386,777,311-3.30-34.06%
1 Month5.8011.1084.8628.6137,742,6550.5910.17%
3 Months8.4111.1084.8628.1916,899,703-2.02-24.02%
6 Months5.2024.903.508.7316,852,4401.1922.88%
1 Year2.6224.902.108.7118,708,8423.77143.89%
3 Years5.4724.900.25437.407,778,0270.9216.82%
5 Years16.8324.900.25437.414,830,522-10.44-62.03%

Vaxart Description

Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.


Your Recent History
NASDAQ
VXRT
Vaxart
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.